A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Jiangsu HengRui Medicine Co., Ltd.
Revolution Medicines, Inc.
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.
Blueprint Medicines Corporation
University of Turin, Italy
Shanghai Gebaide Biotechnology Co., Ltd.
Wenzhou Medical University
Capital Medical University